In vivo enalapril-induced acantholysis.
Enalapril is a widely used antihypertensive drug with a very powerful in vitro acantholytic effect. It has been known to potentially induce pemphigus in genetically predisposed subjects. The action mechanism is complex and still only partially understood. We describe the case of a 66-year-old man, affected with intermediary basal cell carcinoma, in whom the histological examination showed suprabasal acantholytic clefts in the perilesional epidermis. Surprisingly a second biopsy taken from the apparently healthy skin of his back confirmed the presence of acantholytic changes. Clinical signs of pemphigus were absent. The patient's history did not reveal any relevant data but a mild arterial hypertension that had been treated for 1 year with 10 mg enalapril. Taking into account the patient's history (enalapril long-term administration), the absence of any bullous or erosive lesions and the histological findings, a diagnosis was made of in vivo enalapril-induced acantholysis.
Lo Schiavo
A
A
Department of Dermatology, 2nd University of Naples School of Medicine and Surgery, Naples, Italy.
Guerrera
V
V
Cozzani
E
E
Aurilia
A
A
Ruocco
E
E
Pinto
F
F
D000051:Acantholysis / Q000139:chemically induced* / Q000473:pathology; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D003937:Diagnosis, Differential; D004656:Enalapril / Q000009:adverse effects*; D006801:Humans; D008297:Male
D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril